Correction: Efficacy and safety of avacopan in the treatment of ANCA-associated vasculitis: a systematic review and meta-analysis (BMC Rheumatology, (2025), 9, 1, (115), 10.1186/s41927-025-00569-w)

0Citations
Citations of this article
4Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Following publication of the original article [1], the author found that in Fig. 2, the column heading “Effect Size (RR) with 9%% CI” should correctly read “Effect Size (RR) with 95% CI.” Therefore, Fig. 2 has been corrected from: To: Forest plot of meta-analysis comparing complement inhibitors and glucocorticoid-sparing agents for disease remission The original article [1] has been updated.

Cite

CITATION STYLE

APA

Aldhuaina, K., & Alghanim, K. (2025, December 1). Correction: Efficacy and safety of avacopan in the treatment of ANCA-associated vasculitis: a systematic review and meta-analysis (BMC Rheumatology, (2025), 9, 1, (115), 10.1186/s41927-025-00569-w). BMC Rheumatology. BioMed Central Ltd. https://doi.org/10.1186/s41927-025-00609-5

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free